These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 8623211

  • 21. Neoral is superior to FK 506 in liver transplantation.
    Levy GA.
    Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293
    [No Abstract] [Full Text] [Related]

  • 22. Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. European FK506 Multicentre Liver Study Group.
    Transplant Proc; 1994 Dec; 26(6):3260-3. PubMed ID: 7527960
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A.
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract] [Full Text] [Related]

  • 26. Tacrolimus (FK506) is superior to cyclosporine in liver transplantation.
    Busuttil RW, Holt CD.
    Transplant Proc; 1997 Oct; 29(1-2):534-8. PubMed ID: 9123119
    [No Abstract] [Full Text] [Related]

  • 27. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
    [No Abstract] [Full Text] [Related]

  • 28. Tacrolimus in solid organ transplantation: an update.
    Shapiro R.
    Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
    Platz KP, Mueller AR, Zytowski M, Bechstein WO, Blumhardt G, Lobeck H, Neuhaus P.
    Transplant Proc; 1995 Feb; 27(1):1111-3. PubMed ID: 7533357
    [No Abstract] [Full Text] [Related]

  • 33. FK 506 rescue therapy in liver transplantation: outcome and complications.
    McDiarmid SV, Klintmalm G, Busuttil RW.
    Transplant Proc; 1991 Dec; 23(6):2996-9. PubMed ID: 1721339
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Patient and graft survival in the European Multicentre Liver Study--FK 506 vs cyclosporin A.
    McMaster P.
    Transpl Int; 1994 Dec; 7 Suppl 1():S32-6. PubMed ID: 11271239
    [Abstract] [Full Text] [Related]

  • 36. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy.
    Ben-Ari Z, Mor E, Shaharabani E, Bar-Nathan N, Shapira Z, Tur-Kaspa R.
    Transplant Proc; 2000 Jun; 32(4):709-10. PubMed ID: 10856553
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rejection: FK 506 for rescue or maintenance.
    Klintmalm GB, Gibbs JF, McMillan R, Backman L, Levy M, Goldstein RM, Husberg BS, Holman MJ, Gonwa TA.
    Transplant Proc; 1993 Apr; 25(2):1914-5. PubMed ID: 7682356
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
    Platz KP, Mueller AR, Neuhaus R, Keck HH, Lobeck H, Neuhaus P.
    Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.